Janssen Scientific Affairs, LLC, 1125 Trenton Harbourton Rd, Titusville, NJ, 08560, USA.
Janssen Research & Development, LLC, 1125 Trenton Harbourton Rd, Titusville, NJ, 08560, USA.
BMC Psychiatry. 2021 May 17;21(1):257. doi: 10.1186/s12888-021-03258-3.
Despite the availability of pharmacologic and nonpharmacologic treatment options, depression continues to be one of the leading causes of disability worldwide. This study evaluated whether depression symptom severity, as measured by PHQ-9 score, of patients diagnosed with MDD is associated with short-term risk of a hospital encounter (ER visit or inpatient stay).
Adults with ≥1 PHQ-9 assessment in an outpatient setting (index date) and ≥ 1 MDD diagnosis within 6 months prior were included from the de-identified Optum Electronic Health Record database (April 2016-June 2019). Patients were categorized by depression symptom severity based on PHQ-9 scores obtained by natural language processing. Crude rates, adjusted absolute risks, and adjusted relative risks of all-cause and MDD-related hospital encounters within 30 days following assessment of depression severity were determined.
The study population consisted of 280,145 patients with MDD and ≥ 1 PHQ-9 assessment in an outpatient setting. Based on PHQ-9 scores, 26.9% of patients were categorized as having none/minimal depression symptom severity, 16.4% as mild, 24.7% as moderate, 19.6% as moderately severe, and 12.5% as severe. Among patients with none/minimal, mild, moderate, moderately severe, and severe depression, the adjusted absolute short-term risks of an initial all-cause hospital encounter were 4.1, 4.4, 4.8, 5.6, and 6.5%, respectively; MDD-related hospital encounter adjusted absolute risks were 0.8, 1.0, 1.3, 1.6, and 2.1%, respectively. Compared to patients with none/minimal depression symptom severity, the adjusted relative risks of an all-cause hospital encounter were 1.60 (95% CI 1.50-1.70) for those with severe, 1.36 (1.29-1.44) for those with moderately severe, 1.18 (1.12-1.25) for those with moderate, and 1.07 (1.00-1.13) for those with mild depression symptom severity.
These study findings indicate that depression symptom severity is a key driver of short-term risk of hospital encounters, emphasizing the need for timely interventions that can ameliorate depression symptom severity.
尽管有药物和非药物治疗选择,抑郁症仍是全球导致残疾的主要原因之一。本研究评估了经 PHQ-9 评分测量的重度抑郁症患者的抑郁症状严重程度与短期内(30 天内)住院风险(急诊就诊或住院治疗)的相关性。
从去标识化的 Optum 电子健康记录数据库(2016 年 4 月至 2019 年 6 月)中,纳入至少有一次门诊就诊(索引日期)且在 6 个月内有至少一次重度抑郁症诊断,并使用自然语言处理方法获得 PHQ-9 评分的成年人。根据 PHQ-9 评分,患者的抑郁症状严重程度分为无/轻度、轻度、中度、中重度和重度。确定评估抑郁严重程度后 30 天内全因和与重度抑郁症相关的住院就诊的粗发生率、调整后的绝对风险和调整后的相对风险。
本研究人群包括 280145 名有重度抑郁症且在门诊就诊时至少有一次 PHQ-9 评估的患者。根据 PHQ-9 评分,26.9%的患者无/轻度抑郁症状,16.4%为轻度,24.7%为中度,19.6%为中重度,12.5%为重度。无/轻度、轻度、中度、中重度和重度抑郁患者的短期全因住院就诊调整后的绝对风险分别为 4.1%、4.4%、4.8%、5.6%和 6.5%;重度抑郁症相关住院就诊的调整后绝对风险分别为 0.8%、1.0%、1.3%、1.6%和 2.1%。与无/轻度抑郁症状的患者相比,全因住院就诊的调整后相对风险分别为 1.60(95%CI 1.50-1.70)、1.36(1.29-1.44)、1.18(1.12-1.25)和 1.07(1.00-1.13)。
这些研究结果表明,抑郁症状严重程度是短期住院风险的关键驱动因素,强调需要及时进行干预以改善抑郁症状严重程度。